The topotecan-vincristine-doxorubicin combination was active and well tolerated in previously treated patients with advanced neuroblastoma.
No takes yet. Share an insight, caveat, or question.
Garaventa et al. (2003) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: